VOYA Investment Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Other funds holding LRMR
DM
BOCH
DCM
DCM
RI
DCM
VOYA Investment Management's LRMR Position: Q2 2026 in Review
VOYA Investment Management opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 13,105 shares worth $40K. The stake represents ﹤0.01% of the portfolio and ranks #2474 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in LRMR as recently as Q2 2025.
VOYA Investment Management first reported a position in LRMR in Q2 2015 and has held it in 19 quarters since. The position peaked at $1,000K in Q1 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.
- VOYA Investment Management held 13,105 shares of Larimar Therapeutics worth $40K as of Q2 2026.
- Larimar Therapeutics was a new VOYA Investment Management position in Q2 2026.
- Larimar Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2474 holding.
- VOYA Investment Management first reported a position in Larimar Therapeutics in Q2 2015 and has held it in 19 quarters since.
- VOYA Investment Management's Larimar Therapeutics position peaked at $1,000K in Q1 2024.
- 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.
Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.